NIT
KRYS icon

NumerixS Investment Technologies’s Krystal Biotech KRYS Stock Holding History

NumerixS Investment Technologies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$4K – 453
2020
Q2 		$4K Buy
+100
New +$4.81K ﹤0.01% 1029
2020
Q1 		– Sell
-200
Closed -$11K – 1132
2019
Q4 		$11K Buy
+200
New +$9.81K ﹤0.01% 977

Other funds holding KRYS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

NumerixS Investment Technologies's KRYS Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Krystal Biotech (KRYS) in Q3 2020, closing a stake of 100 shares — an estimated $4K sold.

NumerixS Investment Technologies first reported a position in KRYS in Q4 2019 and held it in 2 quarters. The position peaked at $11K in Q4 2019. 98 funds tracked by Wall St. Rank hold KRYS as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Krystal Biotech position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 100 Krystal Biotech shares in Q3 2020, an estimated $4K.
  • NumerixS Investment Technologies first reported a position in Krystal Biotech in Q4 2019 and held it in 2 quarters.
  • NumerixS Investment Technologies's Krystal Biotech position peaked at $11K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.